177 related articles for article (PubMed ID: 24987951)
1. Protein tyrosine kinase 7 (PTK7) as a predictor of lymph node metastases and a novel prognostic biomarker in patients with prostate cancer.
Zhang H; Wang A; Qi S; Cheng S; Yao B; Xu Y
Int J Mol Sci; 2014 Jul; 15(7):11665-77. PubMed ID: 24987951
[TBL] [Abstract][Full Text] [Related]
2. PTK7 expression is associated with lymph node metastasis, ALK and EGFR mutations in lung adenocarcinomas.
Jiang W; He J; Lv B; Xi X; He G; He J
Histol Histopathol; 2020 May; 35(5):489-495. PubMed ID: 31701509
[TBL] [Abstract][Full Text] [Related]
3. The Increased PTK7 Expression Is a Malignant Factor in Cervical Cancer.
Sun JJ; Li HL; Guo SJ; Ma H; Liu SJ; Liu D; Xue FX
Dis Markers; 2019; 2019():5380197. PubMed ID: 30944666
[TBL] [Abstract][Full Text] [Related]
4. PTK7 as a novel marker for favorable gastric cancer patient survival.
Lin Y; Zhang LH; Wang XH; Xing XF; Cheng XJ; Dong B; Hu Y; Du H; Li YA; Zhu YB; Ding N; Du YX; Li JY; Ji JF
J Surg Oncol; 2012 Dec; 106(7):880-6. PubMed ID: 22585737
[TBL] [Abstract][Full Text] [Related]
5. PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.
Tian X; Yan L; Zhang D; Guan X; Dong B; Zhao M; Hao C
Oncol Rep; 2016 Oct; 36(4):1829-36. PubMed ID: 27499181
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of LIMK1 expression in prostate cancer is correlated with poor pathological features, lymph node metastases and biochemical recurrence.
Huang JB; Wu YP; Lin YZ; Cai H; Chen SH; Sun XL; Li XD; Wei Y; Zheng QS; Xu N; Xue XY
J Cell Mol Med; 2020 Apr; 24(8):4698-4706. PubMed ID: 32168432
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma.
Shin WS; Kwon J; Lee HW; Kang MC; Na HW; Lee ST; Park JH
Cancer Sci; 2013 Aug; 104(8):1120-6. PubMed ID: 23663482
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer.
Xu N; Chen HJ; Chen SH; Xue XY; Chen H; Zheng QS; Wei Y; Li XD; Huang JB; Cai H; Sun XL
Medicine (Baltimore); 2016 Jul; 95(29):e4326. PubMed ID: 27442684
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.
Lhoumeau AC; Martinez S; Boher JM; Monges G; Castellano R; Goubard A; Doremus M; Poizat F; Lelong B; de Chaisemartin C; Bardin F; Viens P; Raoul JL; Prebet T; Aurrand-Lions M; Borg JP; Gonçalves A
PLoS One; 2015; 10(5):e0123768. PubMed ID: 25962058
[TBL] [Abstract][Full Text] [Related]
10. PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement.
Gärtner S; Gunesch A; Knyazeva T; Wolf P; Högel B; Eiermann W; Ullrich A; Knyazev P; Ataseven B
PLoS One; 2014; 9(1):e84472. PubMed ID: 24409301
[TBL] [Abstract][Full Text] [Related]
11. ENST00000489707.5 Is a Preferred Alternative Splicing Variant of PTK7 in Adrenocortical Cancer and Shows Potential Prognostic Value.
Bie J; Liu K; Song G; Hu X; Xiong R; Zhang X; Shi X; Wang Z
Med Sci Monit; 2019 Nov; 25():8326-8334. PubMed ID: 31689287
[TBL] [Abstract][Full Text] [Related]
12. High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma.
Jin J; Ryu HS; Lee KB; Jang JJ
PLoS One; 2014; 9(2):e90247. PubMed ID: 24587299
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of PCDH10 predicts worse biochemical recurrence-free survival in patients with prostate cancer after radical prostatectomy.
Wang L; Xie PG; Lin YL; Ma JG; Li WP
Med Sci Monit; 2014 Aug; 20():1363-8. PubMed ID: 25086586
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
15. PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma.
Liu K; Song G; Zhang X; Li Q; Zhao Y; Zhou Y; Xiong R; Hu X; Tang Z; Feng G
World J Surg Oncol; 2017 May; 15(1):105. PubMed ID: 28545451
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma.
Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL
Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575
[TBL] [Abstract][Full Text] [Related]
17. PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis.
Wang H; Li G; Yin Y; Wang J; Wang H; Wei W; Guo Q; Ma H; Shi Q; Zhou X; Wang J
Int J Clin Exp Pathol; 2014; 7(11):7881-9. PubMed ID: 25550828
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer.
Guo J; Wang M; Wang Z; Liu X
PLoS One; 2016; 11(8):e0158667. PubMed ID: 27537362
[TBL] [Abstract][Full Text] [Related]
19. The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly efficient proteolytic target of membrane type-1 matrix metalloproteinase: implications in cancer and embryogenesis.
Golubkov VS; Chekanov AV; Cieplak P; Aleshin AE; Chernov AV; Zhu W; Radichev IA; Zhang D; Dong PD; Strongin AY
J Biol Chem; 2010 Nov; 285(46):35740-9. PubMed ID: 20837484
[TBL] [Abstract][Full Text] [Related]
20. Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7-dependent pathway.
Lee HK; Chauhan SK; Kay E; Dana R
Blood; 2011 May; 117(21):5762-71. PubMed ID: 21460247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
